ISH-based HER2 diagnostics.
Rüschoff J, Nagelmeier I, Jasani B, Stoss O.
Pathologe. 2021 Nov;42(Suppl 1):62-68. doi: 10.1007/s00292-020-00878-6. Epub 2020 Dec 21.
Photodynamic therapy.
Dougherty TJ, Marcus SL.
Eur J Cancer. 1992;28A(10):1734-42. doi: 10.1016/0959-8049(92)90080-l.
Outcomes after sublobar resection versus lobectomy in non-small cell carcinoma in situ.
Perez Holguin RA, Olecki EJ, Wong WG, Stahl KA, Go PH, Taylor MD, Reed MF, Shen C.
J Thorac Cardiovasc Surg. 2023 Mar;165(3):853-861.e3. doi: 10.1016/j.jtcvs.2022.05.032. Epub 2022 Jun 1.
LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y, Jiang X, Duan L, Xiong Q, Yuan Y, Liu P, Jiang L, Shen Q, Zhao S, Yang C, Chen Y.
Mol Cancer. 2021 Dec 2;20(1):156. doi: 10.1186/s12943-021-01469-6.
The natural history of carcinoma in situ involving bronchial resection margins.
Pasic A, Grünberg K, Mooi WJ, Paul MA, Postmus PE, Sutedja TG.
Chest. 2005 Sep;128(3):1736-41. doi: 10.1378/chest.128.3.1736.
Pulmonary preinvasive neoplasia.
Kerr KM.
J Clin Pathol. 2001 Apr;54(4):257-71. doi: 10.1136/jcp.54.4.257.
Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors.
Zito Marino F, Brunelli M, Rossi G, Calabrese G, Caliò A, Nardiello P, Martignoni G, Squire JA, Cheng L, Massi D, Franco R.
Expert Rev Mol Diagn. 2021 Feb;21(2):161-173. doi: 10.1080/14737159.2021.1887733. Epub 2021 Feb 22.
Diagnosis and Treatment of Three Cases of Bronchial Carcinoma In Situ.
Andreev VY, Yanev NA, Stanimirov SK, Mircheva TV, Ivanov IN, Popovska S, Hristova PA, Ivanov YY.
Folia Med (Plovdiv). 2018 Mar 1;60(1):164-169. doi: 10.1515/folmed-2017-0062.
Histologic and Molecular Characterization of Non-Small Cell Lung Carcinoma With Discordant ROS1 Immunohistochemistry and Fluorescence In Situ Hybridization.
Wilcock DM, Schmidt RL, Furtado LV, Matynia AP, Deftereos G, Sirohi D.
Appl Immunohistochem Mol Morphol. 2022 Jan 1;30(1):19-26. doi: 10.1097/PAI.0000000000000973.
Correlation between immunohistochemistry and RICTOR fluorescence in situ hybridization amplification in small cell lung carcinoma.
Krencz I, Sebestyen A, Papay J, Lou Y, Lutz GF, Majewicz TL, Khoor A.
Hum Pathol. 2019 Nov;93:74-80. doi: 10.1016/j.humpath.2019.08.018. Epub 2019 Aug 24.
